NCT05816239 is a clinical trial of Dual Energy CT in Lung Perfusion, sponsored by Sameer Avasarala.

Who is sponsoring NCT05816239?

NCT05816239 is sponsored by Sameer Avasarala.

What drugs are being tested in NCT05816239?

Interventions in NCT05816239: Dual Energy CT.

What condition does NCT05816239 study?

NCT05816239 studies Lung Perfusion.

Is NCT05816239 still recruiting?

NCT05816239 is currently completed. Last updated 3 September 2025.

Last reviewed 2025-09-03 · How we verify

NCT05816239

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

LUng voluMe reductIoN by DuAl ENergy CT Evaluation (LUMINANCE) Study

Completed Last updated 3 September 2025

What this trial tests

trial testing Dual Energy CT in Lung Perfusion in 13 participants. Completed in 24 May 2025.

Timeline

24 February 2023

Primary endpoint
24 May 2025

24 May 2025

Quick facts

Lead sponsor	Sameer Avasarala
Status	Completed
Study type	OBSERVATIONAL
Enrollment	13
Start date	24 February 2023
Primary completion	24 May 2025
Estimated completion	24 May 2025
Sites	1 location across United States

Drugs / interventions tested

Dual Energy CT

Conditions studied

Lung Perfusion — all drugs for Lung Perfusion →

Sponsor

Sameer Avasarala

Who can join

18 and older, any sex, with Lung Perfusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research study is to see if a special CT scan (dual-energy CT) provides useful information in patients undergoing bronchsoscopic lung volume reduction (valve placement for emphysema). The investigators will enroll up to 30 participants in this study from University Hospitals Cleveland Medical Center. All of the participants from this study will undergo their valve procedure at University Hospitals Cleveland Medical Center.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Dual Energy CT

Trials testing the same drug.

NCT05758701 — CT TAVR Abdomen Study · Phase 4 · recruiting
NCT03404076 — Unifying Advanced Treatment With Advanced Imaging · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05816239 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sameer Avasarala
Last refreshed: 3 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05816239.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing